EUVIMEDOpdag EUVIMED
FallberichtOpen access · CC BY-NC 4.0

Progressive Amyloid‐Related Imaging Abnormalities After Discontinuation of Lecanemab in Early Alzheimer Disease in an APOE ε2/ε4 Carrier

Elisabeth Stögmann iD, Lukas Haider iD, Joel Leinkauf iD, Thomas Nakuz, Helena Untersteiner iD, Clemens Farr, Sara Silvaieh, Tandis Parvizi iD, Raphael Wurm iD, Gregor Kasprian iD, Thomas Berger iD, Ellen Gelpi iD and 1 more

European Journal of Neurology · 2026-10 · 33 (10)

DOI: 10.1111/ene.70779 ↗

At a glance

Fallbericht in European Journal of Neurology, published online on 2026-10-12. Written by Elisabeth Stögmann and 12 co-authors. Institution: Department of Neurology, Medical University of Vienna, Wien, Austria. Major MEDLINE topics: Alzheimer Disease, Antibodies, Monoclonal, Humanized. Cited 1 times so far (Crossref); 7 references. The full text is freely available (open access, CC BY-NC 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Amyloid‐related imaging abnormalities (ARIA) are the most relevant adverse events associated with anti‐amyloid therapies in Alzheimer's disease.

Methods

We report a case of progressive ARIA after discontinuation of lecanemab in a patient with early‐onset Alzheimer's disease carrying the rare APOE ε2/ε4 genotype.

Results

After two infusions, mild ARIA‐edema (ARIA‐E) and ARIA‐hemorrhage (ARIA‐H) were detected on routine MRI, prompting treatment interruption. Despite partial radiologic regression, follow‐up MRI 8 weeks after discontinuation demonstrated marked progression with multifocal ARIA‐H displaying as superficial siderosis, while the patient remained clinically asymptomatic. Corticosteroid treatment was initiated and lecanemab permanently discontinued.

Conclusion

This case highlights that severe ARIA may progress beyond active treatment exposure and emphasizes the importance of continued MRI surveillance even after therapy cessation. Furthermore, the APOE ε2/ε4 genotype may represent a distinct risk factor for cerebral amyloid angiopathy‐related vascular fragility and hemorrhagic ARIA.

Subjects

MeSH terms (MEDLINE)

Alzheimer DiseaseAntibodies, Monoclonal, HumanizedHumansApolipoprotein E2Apolipoprotein E4BrainDisease ProgressionHeterozygoteMagnetic Resonance Imaging

Author keywords

APOE ε2/ε4ARIAAlzheimer's diseasecerebral amyloid angiopathylecanemab

Substances

Antibodies, Monoclonal, HumanizedApolipoprotein E2Apolipoprotein E4

Authors and institutions

  • Department of Neurology, Medical University of Vienna, Wien, Austria.
  • Comprehensive Center for Clinical Neurosciences & Mental Health, Medical University of Vienna, Wien, Austria.
  • Division of General and Paediatric Radiology, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Wien, Austria.
  • Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Wien, Austria.
  • Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Wien, Austria.

ORCID profiles: Elisabeth Stögmann, Lukas Haider, Joel Leinkauf, Helena Untersteiner, Tandis Parvizi, Raphael Wurm, Gregor Kasprian, Thomas Berger, Ellen Gelpi, Evelyn Berger Sieczkowski

Cite

APA

Stögmann, E., Haider, L., Leinkauf, J., Nakuz, T., Untersteiner, H., Farr, C., Silvaieh, S., Parvizi, T., Wurm, R., Kasprian, G., Berger, T., Gelpi, E., & Sieczkowski, E. B. (2026). Progressive Amyloid‐Related Imaging Abnormalities After Discontinuation of Lecanemab in Early Alzheimer Disease in an APOE ε2/ε4 Carrier. European Journal of Neurology, 33(10). https://doi.org/10.1111/ene.70779

Vancouver

Stögmann E, Haider L, Leinkauf J, Nakuz T, Untersteiner H, Farr C, et al. Progressive Amyloid‐Related Imaging Abnormalities After Discontinuation of Lecanemab in Early Alzheimer Disease in an APOE ε2/ε4 Carrier. European Journal of Neurology. 2026;33(10). doi:10.1111/ene.70779

BibTeX
@article{Stgmann2026,
  author = {Stögmann, Elisabeth and Haider, Lukas and Leinkauf, Joel and Nakuz, Thomas and Untersteiner, Helena and Farr, Clemens and Silvaieh, Sara and Parvizi, Tandis and Wurm, Raphael and Kasprian, Gregor and Berger, Thomas and Gelpi, Ellen and Sieczkowski, Evelyn Berger},
  title = {Progressive Amyloid‐Related Imaging Abnormalities After Discontinuation of Lecanemab in Early Alzheimer Disease in an APOE ε2/ε4 Carrier},
  journal = {European Journal of Neurology},
  year = {2026},
  volume = {33},
  number = {10},
  doi = {10.1111/ene.70779}
}
Start for free →